Ad is loading...
ADNRX vs RPTIX
ADNRX vs RPTIX Comparison
Open Charts ADNRX vs RPTIX
American Beacon ARK Transfmt Innov R6
Price$16.27
Change-$0.03 (-0.18%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$101.17
Change-$0.05 (-0.05%)
VolumeN/A
CapitalizationN/A
ADNRX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RPTIX commentary
Dec 25, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RPTIX is a Buy.
FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 30.6B vs. ADNRX (217M). RPTIX pays higher dividends than ADNRX: RPTIX (0.18) vs ADNRX (0.00). ADNRX was incepted earlier than RPTIX: ADNRX (4 years) vs RPTIX (9 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RPTIX (21.70). ADNRX has a lower initial minimum investment than RPTIX: ADNRX (0) vs RPTIX (500000). ADNRX annual gain was more profitable for investors over the last year : 12.21 vs. RPTIX (1.31).
| ADNRX | RPTIX | ADNRX / RPTIX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 9 years | - |
| Gain YTD | 13.301 | 0.968 | 1,374% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 217M | 30.6B | 1% |
| Annual Yield % from dividends | 0.00 | 0.18 | - |
| Returns for 1 year | 12.21 | 1.31 | 931% |
| Returns for 3 years | -43.19 | -12.65 | 341% |
| Returns for 5 years | N/A | 6.31 | - |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...